2023 JDRF Australia PhD scholarships announced
JDRF Australia is delighted to announce the recipients of our 2023 PhD top-up scholarships: Rachel Hicks from Western Sydney University and Amanda Purcell from The Kolling Institute.
The top-up scholarship is designed to support and encourage PhD students pursuing research in the field of type 1 diabetes (T1D) in line with JDRF’s mission – to treat, prevent and cure T1D. The competitive scholarship selects the best and brightest scientists in the field to ensure the next generation of T1D researchers can carry out their ground-breaking research.
Our first recipient, Rachel, is investigating the perspectives of pregnant women with diabetes with the aim of improving pregnancy outcomes and medical care. Rachel will look at how pregnant women living with diabetes interact with the health care system and how they perceive pregnancy care. Rachel will also undertake a pilot study to improve communication with health care practitioners and develop a service model to improve the engagement of women diagnosed with gestational diabetes.
The overall aims of Rachel’s project are to support women with diabetes through their pregnancies and strengthen ties between healthcare professionals and consumers in working together to advocate for better health outcomes.
Of her top-up scholarship, Rachel says: “I feel so honoured and grateful as a person with type 1 diabetes and researcher to receive this top-up scholarship. This scholarship will enable me to successfully continue my studies whilst supporting my young family, so I can help cultivate in them a lifelong love of learning. It also allows me to pursue additional opportunities to attend and present at domestic and international conferences and collaborate further with the global diabetes community. I am so thankful to JDRF for this opportunity!”.
Our second recipient, Amanda, will investigate a drug called semaglutide to see if it can be used to treat diabetic kidney disease (DKD) in those with T1D and obesity.
T1D often leads to complications, including DKD which can be life-threatening. Unfortunately, the incidence of T1D is increasing, and obesity is also on the rise among individuals living with T1D, which can make blood glucose management more complex.
Semaglutide is widely used in type 2 diabetes to induce weight loss and improve how cells respond to insulin. It is also used to delay progression of DKD in those with type 2 diabetes, but it is not known whether it would have these same benefits in those with T1D.
Using a pre-clinical model, Amanda’s project aims to determine if using semaglutide in cases of T1D and obesity can improve kidney health. The findings from this work will influence preventative care for DKD in people with T1D and obesity.
Of receiving the PhD top up scholarship, Amanda said “The JDRF PhD Top Up Scholarship represents an opportunity to create meaningful change and gives me the privilege to be part of a community dedicated to making a difference in the lives of people with type 1 diabetes. This support will provide me with the opportunity to attend conferences and workshops, allowing me to connect with experts in the field and share my research findings.”
Why the scholarships are important
JDRF Australia continues to support excellence in research and clinical care in the field of T1D. We are committed to supporting up-and-coming researchers in T1D so that they can continue to undertake their ground-breaking work in the future. We have a number of opportunities for early career researchers, including PhD top-up scholarships and travel grants, to ensure future breakthroughs in the T1D space are ensured.
At JDRF Australia we are passionate about not only supporting well-established T1D scientists who are leading the field, but also the best early career researchers, to foster the future T1D researcher pipeline and ensure breakthroughs can continue to happen now and in the years to come,” said Dr Dorota Pawlak, Chief Scientific Officer, JDRF Australia.
About the PhD top-up scholarships
JDRF Australia provides PhD scholars with a top-up of up to $6,000 per year for a maximum of three years to supplement their PhD stipend. The top up scholarship allows PhD scholars to attend scientific conferences, to present their findings and to establish critical networks with other researchers both nationally and internationally. The scholarships are competitively assigned and are part of our commitment to nurturing the next generation of talented T1D researchers.
See what past PhD top-up scholarship recipients said about their award.
Head to our website for current research funding opportunities.
Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop
Are you passionate about creating a world where research breakthroughs in type 1 diabetes (T1D) are rapidly turned into tangible treatments; a world where the most promising discoveries don’t just remain in labs but make their way swiftly to those who need them the most? Do you have a pioneering research project, innovative idea, or […]
Fiasp insulin to remain on the Pharmaceutical Benefits Scheme
MEDIA RELEASE Fiasp insulin to remain on the Pharmaceutical Benefits Scheme The new listing of Fiasp® Penfill® on the Pharmaceutical Benefits Scheme will keep the life-saving medication available to the 15,000+ Australians who rely on it Sydney, 18 September 2023: JDRF Australia is welcoming an announcement from Minister for Health, Hon Mark Butler, that Fiasp […]
Type 1 diabetes and women’s health: periods and menopause
We all know how powerful hormones can be in controlling menstrual cycles, so it’s no surprise that they can also affect blood glucose levels. This can also make life a bit more challenging for women living with type 1 diabetes (T1D). In our book for adults living with T1D, Straight to the Point, we look […]
Support for siblings of children living with type 1 diabetes
If you have experience with type 1 diabetes (T1D), you’ll know that it can affect the whole family. And siblings of a child living with T1D can also be impacted by their brother or sister’s diagnosis. Although they’re not the ones being treated for T1D, siblings can be significantly impacted in lots of other ways. […]